SEC Form 4 · accession 0001209191-15-064914
Viridian Therapeutics, Inc.\DE · VRDN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas A Schuling
Director
Period of report
Aug 6, 2015
Accepted (ET)
Aug 10, 2015 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590750
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 6, 2015 | M | 4,125 | — | A | 5,500 | D | |
| Common StockF2 | Aug 6, 2015 | A | 5,000 | $0.00 | A | 10,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1 | — | Aug 6, 2015 | M | 4,125 | D | — | — | Common Stock | 4,125 | 0 | D |
| Stock Option (Right to Buy)F3 | $1.62 | Aug 6, 2015 | A | 18,000 | A | — | Aug 6, 2025 | Common Stock | 18,000 | 18,000 | D |
Explanation of responses
- F1On August 6, 2015, the Issuer's Board of Directors approved the acceleration of the vesting of the restricted stock units previously reported by the reporting person on Form 4 filed with the Securities and Exchange Commission on July 21, 2014 such that all of the restricted stock units converted into common stock on a one-to-one basis on August 6, 2015.
- F2Represents shares of common stock underlying restricted stock units granted to the reporting person on August 6, 2015. The restricted stock units are fully vested on the date of the grant.
- F3The option shall vest and become exercisable in ten equal monthly installments beginning on August 31, 2015 and ending on May 31, 2016.